SciBase announces exclusive distribution agreement for Great Britain with Globe Skincare
Press Release Globe SciBase Sep 2014SciBase, a leader in skin cancer detection technology with its unique point-of-care device Nevisense, today announced that it has entered into an exclusive agreement with Globe Skincare Ltd to distribute Nevisense in Great Britain. UK-based Globe Skincare is a leading distributor of skin care and analysis products to the dermatological community across Great Britain. Nevisense is an important new tool for the detection of malignant melanoma, the most fatal form of skin cancer. The ability of Nevisense to accurately detect melanoma has been proven in